X0306 4 2021-09-01 false 0001603756 Axonics, Inc. AXNX 0001756437 Woock John 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false Chief Marketing Officer Common Stock 2021-09-01 4 M false 5000.00 1.63 A 34932.00 D Common Stock 2021-09-01 4 S false 8443.00 74.7264 D 26489.00 D Common Stock 2021-09-02 4 S false 1557.00 75.5793 D 24932.00 D Stock Option (Right to Buy) 1.63 2021-09-01 4 M false 3443.00 0.00 D 2028-03-30 Common Stock 3443.00 12757.00 D Stock Option (Right to Buy) 1.63 2021-09-02 4 M false 1557.00 0.00 D 2028-03-30 Common Stock 1557.00 11200.00 D This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021. This transaction was executed in multiple trades at prices ranging from $73.82 to $75.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $75.00 to $76.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. /s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D 2021-09-03